INIS
patients
100%
receptors
60%
ethics
57%
covid-19
44%
strychnine
40%
glycine
40%
neurons
40%
rats
40%
cancer
40%
dynamics
40%
interventions
29%
risks
28%
levels
27%
applications
26%
values
26%
norm
24%
adults
23%
adenosine
20%
inhibition
20%
internal medicine
20%
proposals
20%
cost
20%
genetics
20%
hospitals
20%
voltage
20%
contracts
20%
universities
17%
diseases
16%
capacity
14%
design
14%
data
13%
resolution
13%
texas
12%
flexibility
12%
delivery
12%
calcium
12%
pipelines
10%
space
10%
information
10%
modifications
10%
coronaviruses
10%
spinal cord
8%
grants
8%
reviews
8%
pharmacology
7%
alignment
6%
policy
6%
tools
5%
comparative evaluations
5%
Keyphrases
Comprehensive Cancer Center
20%
Unplanned Readmission
20%
Multi-voltage
20%
Relational Dynamics
20%
Machination
20%
Healthcare Enterprises
20%
Equitable Healthcare
20%
Monetary Units
20%
Agonist Efficacy
20%
30-day Readmission
20%
Hospitalist
20%
Translational Ethics
20%
General Internal Medicine
20%
Readmission
16%
Readmission Rate
12%
Institutional Safeguards
10%
Scientific Curiosity
10%
Political Pressure
10%
Research pipeline
10%
Patients with Cancer
8%
Risk Factors
8%
Comorbidity
8%
Cancer Hospital
8%
Proposal Writing
6%
Pace of Technological Innovation
6%
Relationship Building
6%
Public Expectations
6%
Regulatory Procedures
6%
Relationship Narratives
6%
Research Enterprise
6%
Human Effort
6%
Ethical Values
6%
Formal Rules
6%
Ethical Competence
6%
Patient Goals
6%
Humanistic Approach
6%
Value Preferences
6%
Neuroscience
Glycine Receptor
40%
Strychnine
40%
Neuron
40%
Basolateral Amygdala
40%
Agonist
25%
Protein Quaternary Structure
23%
Eicosanoid Receptor
23%
Cyanocobalamin
20%
2 Chloroadenosine
20%
Adenosine A1 Receptor
20%
Calcium Channel
20%
Amygdala
17%
Forebrain
17%
Gene Expression System
14%
Heterologous Expression
11%
Spinal Cord
11%
Adenosine
8%
Brainstem
8%
Voltage Gated Calcium Channel
5%
Anticonvulsant
5%
